Search results
Results from the WOW.Com Content Network
Fanconi anemia group D2 protein is a protein that in humans is encoded by the FANCD2 gene. [4] [5] The Fanconi anemia complementation group currently includes FANCA ...
Prophylactic mastectomy should be considered for women that had breast cancer and a PALB2 mutation. [21] [22] Biallelic mutations in PALB2 (also known as FANCN), similar to biallelic BRCA2 mutations, cause Fanconi anemia. [7] Mutations in this gene have been associated with an increased risk of ovarian, breast and pancreatic cancer. [23]
Condition name ICD-10 coding number Diseases Database coding number Medical Subject Headings Iron-deficiency anemia: D50: 6947: Iron-deficiency anemia (or iron deficiency anaemia) is a common anemia that occurs when iron loss (often from intestinal bleeding or menses) occurs, and/or the dietary intake or absorption of iron is insufficient.
It stimulates erythropoiesis (increasing red blood cell levels) and is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy. Epoetin alfa is developed by Amgen. [8] It is on the World Health Organization's List of Essential Medicines. [10] It was approved for medical use in the European Union in August 2007,
Fanconi anemia, complementation group M, also known as FANCM is a human gene. [ 5 ] [ 6 ] It is an emerging target in cancer therapy, in particular cancers with specific genetic deficiencies. [ 7 ] [ 8 ]
Fanconi anemia (FA) is a rare, autosomal recessive, genetic disease resulting in impaired response to DNA damage in the FA/BRCA pathway. Although it is a very rare disorder, study of this and other bone marrow failure syndromes has improved scientific understanding of the mechanisms of normal bone marrow function and development of cancer.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Burtness left the Fox Chase Cancer Center in 2014 to return to Yale University as a Professor of Medicine and their Clinical Research Program Leader of the Head and Neck Cancers Program. [6] In this role, she was nominated for the 2018 Women Who Conquer Cancer Mentorship Award [7] and again named to the Best Doctors List. [8]